The 36-month beta value for XRAY is also noteworthy at 0.96. There are mixed opinions on the stock, with 2 analysts rating it as a “buy,” 2 rating it as “overweight,” 13 rating it as “hold,” and 0 rating it as “sell.”
The public float for XRAY is 197.77M, and at present, short sellers hold a 4.24% of that float. The average trading volume of XRAY on July 09, 2025 was 2.81M shares.
XRAY) stock’s latest price update
DENTSPLY Sirona Inc (NASDAQ: XRAY) has experienced a rise in its stock price by 3.70% compared to its previous closing price of $15.94. However, the company has seen a gain of 4.09% in its stock price over the last five trading days. zacks.com reported 2025-07-03 that Whether you’re a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
XRAY’s Market Performance
DENTSPLY Sirona Inc (XRAY) has seen a 4.09% rise in stock performance for the week, with a 3.96% gain in the past month and a 21.72% surge in the past quarter. The volatility ratio for the week is 4.41%, and the volatility levels for the past 30 days are at 3.06% for XRAY. The simple moving average for the past 20 days is 3.43% for XRAY’s stock, with a -9.78% simple moving average for the past 200 days.
Analysts’ Opinion of XRAY
Many brokerage firms have already submitted their reports for XRAY stocks, with Morgan Stanley repeating the rating for XRAY by listing it as a “Equal-Weight.” The predicted price for XRAY in the upcoming period, according to Morgan Stanley is $14 based on the research report published on April 15, 2025 of the current year 2025.
Wells Fargo gave a rating of “Equal Weight” to XRAY, setting the target price at $20 in the report published on February 14th of the current year.
XRAY Trading at 5.45% from the 50-Day Moving Average
After a stumble in the market that brought XRAY to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -40.86% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at XRAY starting from LUCIER GREGORY T, who purchase 15,142 shares at the price of $16.51 back on Mar 03 ’25. After this action, LUCIER GREGORY T now owns 81,971 shares of DENTSPLY Sirona Inc, valued at $249,994 using the latest closing price.
Stock Fundamentals for XRAY
Current profitability levels for the company are sitting at:
- -0.22 for the present operating margin
- 0.52 for the gross margin
The net margin for DENTSPLY Sirona Inc stands at -0.24. The total capital return value is set at -0.2. Equity return is now at value -34.47, with -13.79 for asset returns.
Based on DENTSPLY Sirona Inc (XRAY), the company’s capital structure generated 0.55 points at debt to capital in total, while cash flow to debt ratio is standing at 0.18. The debt to equity ratio resting at 1.21. The interest coverage ratio of the stock is -11.93.
Currently, EBITDA for the company is -532.0 million with net debt to EBITDA at -3.52. When we switch over and look at the enterprise to sales, we see a ratio of 1.43. The receivables turnover for the company is 6.16for trailing twelve months and the total asset turnover is 0.61. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.10.
Conclusion
In summary, DENTSPLY Sirona Inc (XRAY) has had a mixed performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
